logo

Passage Bio, Inc. (PASG)



Trade PASG now with
  Date
  Headline
12/17/2021 7:14:56 AM Passage Bio: IDMC Recommended Proceeding To Additional Planned Cohorts In Imagine-1 Clinical Study
9/7/2021 7:15:26 AM Passage Bio Names Maxine Gowen Chairwoman Of Board Of Directors
7/19/2021 7:10:33 AM Passage Bio Names Maria Törnsén Chief Commercial Officer
6/1/2021 7:13:13 AM Passage Bio Adds Derrell Porter To Its Board
4/5/2021 7:04:22 AM Passage Bio Says European Commission Has Granted Orphan Designation For PBKR03
4/1/2021 7:16:26 AM Passage Bio Says First Patient Dosed In Global Phase 1/2 Clinical Trial Program For PBGM01
3/22/2021 7:21:36 AM Passage Bio Appoints Eliseo Salinas As Chief Research & Development Officer
3/8/2021 7:15:39 AM Passage Bio Says FDA Grants Fast Track Designation To Three Gene Therapy Candidates Targeting Rare CNS Disorders
1/21/2021 9:04:33 PM Passage Bio Prices Public Offering Of 7 Mln Shares Of Common Stock At $22.00/shr
10/26/2020 7:17:21 AM Passage Bio: EC Grants Orphan Drug Designation For PBGM01 For The Treatment Of GM1 Gangliosidosis
5/21/2020 8:12:54 AM Passage Bio: FDA Grants Rare Pediatric Disease Designation For PBGM01 For Patients With GM1 Gangliosidosis
3/5/2020 8:17:51 AM Passage Bio Adds Athena Countouriotis To Board
2/27/2020 7:57:42 PM Passage Bio Prices IPO Of 12 Mln Shares At $18.00/shr